New Zealand markets closed
  • NZX 50

    11,200.04
    +80.47 (+0.72%)
     
  • NZD/USD

    0.5666
    -0.0065 (-1.13%)
     
  • ALL ORDS

    6,760.60
    +100.80 (+1.51%)
     
  • OIL

    81.12
    -1.03 (-1.25%)
     
  • GOLD

    1,654.40
    -15.60 (-0.93%)
     

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at John F. Kennedy International Airport’s Terminal 4

·3-min read
XpresSpa Group, Inc.
XpresSpa Group, Inc.

Resurgence of Travel Sees Surge in Demand of Airport Self-care Solutions and Amenities for Passengers

XpresSpa at JFK Terminal 4

XpresSpa Re-Opening at JFK, Terminal 4 Gate B22.
XpresSpa Re-Opening at JFK, Terminal 4 Gate B22.

NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) ("XpresSpa" or the "Company"), a health and wellness company, announced the re-opening of one of its top-performing XpresSpa™ locations at John F. Kennedy (JFK) International Airport’s Terminal 4.  

Located in Terminal 4 near Gate B22, the re-opened XpresSpa will meet the needs of a new era of post-pandemic travelers—health-conscious air passengers seeking more self-care solutions and amenities—by providing traditional wellness services, such as neck and back massage, as well as state-of-the-art solutions incorporating technology that gives therapeutic relief with minimal intervention. The refreshed space also will offer a wider selection of retail products to help passengers manage their well-being while on the go.

"We are thrilled to re-open one of our most popular locations which offers a retreat for travelers seeking a more relaxing environment in one of the busiest airports in the world," said XpresSpa Group CEO Scott Milford. "As travelers return to airports, XpresSpa is dedicated to providing exceptional wellness experiences for people on-the-go. We thank our partners at JFK for their ongoing support and look forward to building on our success domestically and abroad as we continue to relaunch and debut new spas internationally.”

Ed Midgley, vice president of customer experience and commercial at JFKIAT, the operator of Terminal 4 at John F. Kennedy International Airport, added, "The safety and wellness of travelers passing through Terminal 4 are of the utmost importance to us. Our partnership with XpresSpa further defines our commitment to adding the best brands to our terminal’s lineup and boosting traveler experience."

XpresSpa operates several other locations within JFK’s Terminal 4 including:

  • XpresCheck, which offers COVID-19 testing;

  • Treat, an upscale health and wellness center; and

  • XpresRecover, a retail location that offers pillows, massagers and stress relief items.

XpresSpa currently operates 26 locations globally. As part of the company's go-forward plan to extend its services and products across international lines, XpresSpa currently operates six international locations, three in Dubai International Airport in the United Arab Emirates and three in Schiphol Amsterdam Airport in the Netherlands. Looking ahead, the company recently announced plans to open an XpresSpa location in Turkey’s Istanbul Airport beginning in September 2022 and expects to leverage its existing footprint in Gulf Cooperation Council countries to open additional operations in Abu Dhabi and across the region in 2023.

About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company operating four brands: XpresCheck®, XpresSpa®, Treat™ and HyperPointe.

  • XpresSpa is a leading airport retailer of wellness services and related products, with 26 locations in 13 airports globally.

  • Treat is a travel health and wellness brand that is providing on-demand access to healthcare through technology and personalized services, including two domestic airport locations.

  • XpresCheck is a leading provider of Covid-19 screening and diagnostic testing with 15 locations in 12 domestic airports. XpresCheck is also partnered with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants.

  • HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.

To learn more about XpresCheck, visit: www.XpresCheck.com
To learn more about XpresSpa, visit www.XpresSpa.com
To learn more about Treat, visit: www.Treat.com
To learn more about HyperPointe, visit: www.HyperPointe.com

Twitter: @xprescheck and Instagram: @realxprescheck
Twitter: @XpresSpa and Instagram: @XpresSpa
Twitter: @Treat_Care and Instagram: @treat_care

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ad747076-ac65-4e9f-b395-c5336d854d88.

CONTACT: Investor Relations Joseph Calabrese MWW ir@xpresspagroup.com Media Heather Tidwell  MWW   htidwell@mww.com